IRIS Accounts Production v25.2.0.378 04886239 Board of Directors 1.1.24 31.12.24 31.12.24 Medium entities the provision of residential and nursing care for the elderly including those living with dementia. true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh048862392023-12-31048862392024-12-31048862392024-01-012024-12-31048862392022-12-31048862392023-01-012023-12-31048862392023-12-3104886239ns15:EnglandWales2024-01-012024-12-3104886239ns14:PoundSterling2024-01-012024-12-3104886239ns10:Director12024-01-012024-12-3104886239ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3104886239ns10:MediumEntities2024-01-012024-12-3104886239ns10:Audited2024-01-012024-12-3104886239ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-01-012024-12-3104886239ns10:Medium-sizedCompaniesRegimeForAccounts2024-01-012024-12-3104886239ns10:FullAccounts2024-01-012024-12-3104886239ns10:OrdinaryShareClass12024-01-012024-12-3104886239ns10:Director22024-01-012024-12-3104886239ns10:CompanySecretary12024-01-012024-12-3104886239ns10:RegisteredOffice2024-01-012024-12-3104886239ns10:Director32024-01-012024-12-3104886239ns5:CurrentFinancialInstruments2024-12-3104886239ns5:CurrentFinancialInstruments2023-12-3104886239ns5:Non-currentFinancialInstruments2024-12-3104886239ns5:Non-currentFinancialInstruments2023-12-3104886239ns5:ShareCapital2024-12-3104886239ns5:ShareCapital2023-12-3104886239ns5:RevaluationReserve2024-12-3104886239ns5:RevaluationReserve2023-12-3104886239ns5:RetainedEarningsAccumulatedLosses2024-12-3104886239ns5:RetainedEarningsAccumulatedLosses2023-12-3104886239ns5:ShareCapital2022-12-3104886239ns5:RetainedEarningsAccumulatedLosses2022-12-3104886239ns5:RevaluationReserve2022-12-3104886239ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-3104886239ns5:RevaluationReserve2023-01-012023-12-3104886239ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-3104886239ns5:RevaluationReserve2024-01-012024-12-3104886239ns5:ReportableOperatingSegment12024-01-012024-12-3104886239ns5:ReportableOperatingSegment12023-01-012023-12-3104886239ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2024-01-012024-12-3104886239ns5:TotalReportableOperatingSegmentsIncludingAnyUnallocatedAmount2023-01-012023-12-3104886239ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2024-01-012024-12-3104886239ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2023-01-012023-12-3104886239ns5:OwnedAssets2024-01-012024-12-3104886239ns5:OwnedAssets2023-01-012023-12-310488623952024-01-012024-12-310488623952023-01-012023-12-3104886239ns5:LandBuildings2023-12-3104886239ns5:PlantMachinery2023-12-3104886239ns5:FurnitureFittings2023-12-3104886239ns5:MotorVehicles2023-12-3104886239ns5:LandBuildings2024-01-012024-12-3104886239ns5:PlantMachinery2024-01-012024-12-3104886239ns5:FurnitureFittings2024-01-012024-12-3104886239ns5:MotorVehicles2024-01-012024-12-3104886239ns5:LandBuildings2024-12-3104886239ns5:PlantMachinery2024-12-3104886239ns5:FurnitureFittings2024-12-3104886239ns5:MotorVehicles2024-12-3104886239ns5:LandBuildings2023-12-3104886239ns5:PlantMachinery2023-12-3104886239ns5:FurnitureFittings2023-12-3104886239ns5:MotorVehicles2023-12-3104886239ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3104886239ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3104886239ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-12-3104886239ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-12-3104886239ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-12-3104886239ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-12-3104886239ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-12-3104886239ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2023-12-3104886239ns5:HirePurchaseContractsns5:BetweenOneFiveYears2024-12-3104886239ns5:HirePurchaseContractsns5:BetweenOneFiveYears2023-12-3104886239ns5:HirePurchaseContracts2024-12-3104886239ns5:HirePurchaseContracts2023-12-3104886239ns5:DeferredTaxation2023-12-3104886239ns5:DeferredTaxation2024-01-012024-12-3104886239ns5:DeferredTaxation2024-12-3104886239ns10:OrdinaryShareClass12024-12-3104886239ns5:RetainedEarningsAccumulatedLosses2023-12-3104886239ns5:RevaluationReserve2023-12-310488623912024-01-012024-12-31
REGISTERED NUMBER: 04886239 (England and Wales)


















Strategic Report, Report of the Directors and

Financial Statements for the Year Ended 31 December 2024

for

Ashberry Healthcare Ltd

Ashberry Healthcare Ltd (Registered number: 04886239)






Contents of the Financial Statements
for the Year Ended 31 December 2024




Page

Company Information 1

Strategic Report 2

Report of the Directors 4

Report of the Independent Auditors 6

Statement of Comprehensive Income 10

Balance Sheet 11

Statement of Changes in Equity 12

Cash Flow Statement 13

Notes to the Cash Flow Statement 14

Notes to the Financial Statements 15


Ashberry Healthcare Ltd

Company Information
for the Year Ended 31 December 2024







DIRECTORS: G B Cottrell
N J Denny





SECRETARY: S Lock





REGISTERED OFFICE: 1 Lea Business Park
Lower Luton Road
HARPENDEN
Hertfordshire
AL5 5EQ





REGISTERED NUMBER: 04886239 (England and Wales)





AUDITORS: GH Audit Limited
Unit 1b
Focus 4
Fourth Avenue
Letchworth
Hertfordshire
SG6 2TU

Ashberry Healthcare Ltd (Registered number: 04886239)

Strategic Report
for the Year Ended 31 December 2024

The directors present their strategic report for the year ended 31 December 2024.

The principal activity of the Company is the provision of residential and nursing care for the elderly including those living with dementia

REVIEW OF BUSINESS
During the year, Ashberry Healthcare benefited from the addition of Engelberg Care Home in Wolverhampton, acquired in March 2024. The home was successfully integrated into the Ashberry culture and operations, achieving full occupancy with a waiting list by the year end.

Occupancy levels across the remainder of the portfolio remained strong, with an average of 92%. The Directors are confident in sustaining this level, supported by a strengthened marketing strategy. In particular, increased use of social media has promoted resident activities, enhanced the visibility of individual homes, and driven enquiries. This approach has contributed to the Company's Trusted Care rating improving to 9.8 out of 10.

A key focus during the year was enhancing resident wellbeing. The newly created Resident Experience Manager role ensures residents enjoy a fulfilling lifestyle, from dining to hobbies and excursions, reflecting the Company's belief that residents should lead as normal and enjoyable a life as possible.

The introduction of day care services has also proven successful. This service has grown steadily, often acting as a gateway to respite and permanent care placements.

In January 2025, Ashberry acquired The Weir Nursing Home Limited, a home with 29 bedrooms situated in National Trust grounds overlooking the River Wye. Detailed planning consent is already in place to extend the facility by a further 10 bedrooms. In addition, the Company is set to complete on a 52-bedroom nursing home in Cheltenham by September 2025, further strengthening its portfolio.

Investment in staff remains a cornerstone of Ashberry's strategy. The Company continues to pay frontline staff at rates above the National Minimum Wage, alongside offering enhanced rates for shift cover. These initiatives have reduced reliance on agency staff and improved workforce stability.

The Directors are also committed to continuous investment in infrastructure and equipment. Opportunities have been identified to expand capacity at several homes, with architects engaged to prepare planning applications. Adding bedrooms is expected to deliver strong returns, given the minimal incremental costs of servicing additional residents.

In line with its corporate responsibilities, the Company has also launched a review of energy usage, exploring more efficient heating systems and sustainable energy sources. These measures are expected to generate significant long-term cost savings.


Ashberry Healthcare Ltd (Registered number: 04886239)

Strategic Report
for the Year Ended 31 December 2024

PRINCIPAL RISKS AND UNCERTAINTIES
Workforce Recruitment and Retention

Recruitment remains a key challenge across the sector. While enhanced pay rates have helped stabilise staffing, the Directors recognise that long-term retention requires a supportive culture. Initiatives include:
- Regular staff surveys to encourage open feedback
- A fortnightly staff bulletin to improve communication
- Annual staff award evenings recognising long service and achievements

These steps have been positively received and have strengthened engagement.

Inflationary Pressures

Rising costs of food, heating, and energy have posed challenges. The Company has acted to mitigate these pressures by:

- Implementing ESOS report recommendations, including replacing older boilers
- Installing Rational ovens, which reduce both energy consumption and food waste
- Securing new electricity and gas contracts from October 2024 on significantly improved tariffs

Government Pressures

The above inflationary increase in National Minimum Wage together with the increase in Employers N.I. have increased the financial burden on the sector. This is compounded by not having a clear strategy for how social care will be funded. The Company has acted to mitigate these pressures by:
- Increased fees charged to residents above the rate of inflation
- Challenge the rates paid by Local Authorities as and when resident dependency needs increases

OUTLOOK
The Directors remain confident in the Company's growth strategy, with further portfolio expansion planned for 2025. Continued investment in staff, infrastructure, and sustainability will ensure Ashberry Healthcare maintains its high standards of care while delivering long-term value.

ON BEHALF OF THE BOARD:





N J Denny - Director


30 September 2025

Ashberry Healthcare Ltd (Registered number: 04886239)

Report of the Directors
for the Year Ended 31 December 2024

The directors present their report with the financial statements of the company for the year ended 31 December 2024.

DIVIDENDS
No dividends will be distributed for the year ended 31 December 2024.

EVENTS SINCE THE END OF THE YEAR
Information relating to events since the end of the year is given in the notes to the financial statements.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 January 2024 to the date of this report.

G B Cottrell
N J Denny

Other changes in directors holding office are as follows:

J Bradford - resigned 31 July 2024

FINANCIAL INSTRUMENTS
The company's principal financial instruments comprise bank balances, trade debtors, trade creditors and loans to the company. The main purpose of these instruments is to finance the company's operations.

In respect of bank balances, the liquidity risk is managed by maintaining a balance between the continuity of funding and flexibility through the use of overdrafts at floating rates of interest. The company's cash balances are held in such a way that achieves a competitive rate of interest.

Trade debtors are managed in respect of credit and cash flow risk by policies concerning the credit offered to customers and the regular monitoring of amounts outstanding for both time and credit limits. The amount presented in the balance sheet are net of allowances and doubtful debtors.

Trade creditors' liquidity risk is managed by ensuring sufficient funds are available to meet the payments.

Loans comprise of loans from financial institutions. The interest rates and monthly repayments are fixed. The company manages the liquidity risk by ensuring that there are sufficient funds to meet payments.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Ashberry Healthcare Ltd (Registered number: 04886239)

Report of the Directors
for the Year Ended 31 December 2024


STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS
The auditors, GH Audit Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





N J Denny - Director


30 September 2025

Report of the Independent Auditors to the Members of
Ashberry Healthcare Ltd

Opinion
We have audited the financial statements of Ashberry Healthcare Ltd (the 'company') for the year ended 31 December 2024 which comprise the Statement of Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Ashberry Healthcare Ltd


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page four, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Ashberry Healthcare Ltd


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We obtained an understanding of the legal and regulatory framework applicable to the Company, and the industry in which it operates by making enquiries of management. We also enquired as to whether there were any instances of non compliance with laws and regulations or whether there were any instances of fraud detected or suspected. The key laws and regulations considered include the UK Companies Act and UK Tax Legislation.

In addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the company’s ability to operate or to avoid a material penalty. These included compliance with Health and Safety legislation and the regulators specifically overseeing the industry.

We obtained an understanding of the Company's operations, including the nature of the company, its control environment, business performance and its key performance indicators.

We considered the extent to which non-compliance would have a material impact on the financial statements. We also evaluated the managements incentives and opportunities for fraudulent manipulation of the financial statements (including the management override of controls) and determined that the principal risks were related to:
- Management bias in accounting estimates; and
- Revenue recognition

We assessed the susceptibility of the Company's financial statements to material misstatement. Audit procedures performed by the engagement team include:
- Enquiries of management about their own identification and assessment of risk of irregularities
- Evaluation of the processes and controls established to address the risk of irregularities and fraud
- Testing manual journals, specifically those relating to large or unusual entries or entries relating to management estimates
- Testing the assumptions and judgements made by management in its significant accounting estimates, including reviewing historical data to assess the appropriateness of previous assessments

We assessed the appropriateness of the competence and capabilities of the engagement team, including the teams knowledge of the industry and the appropriateness of their practical experience through training and participation with audit engagements of a similar nature.

We also communicated the relevant laws and regulations and fraud risk indicators to the engagement team and remained vigilant throughout the audit process for indications of fraud or non-compliance.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Ashberry Healthcare Ltd


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Emma Wilsher FCA (Senior Statutory Auditor)
for and on behalf of GH Audit Limited
Unit 1b
Focus 4
Fourth Avenue
Letchworth
Hertfordshire
SG6 2TU

30 September 2025

Ashberry Healthcare Ltd (Registered number: 04886239)

Statement of Comprehensive
Income
for the Year Ended 31 December 2024

2024 2023
Notes £    £   

TURNOVER 3 14,451,095 12,525,049

Cost of sales 10,693,980 9,230,718
GROSS PROFIT 3,757,115 3,294,331

Administrative expenses 2,530,789 2,331,416
1,226,326 962,915

Other operating income 31,219 62,072
OPERATING PROFIT 5 1,257,545 1,024,987

Exceptional items 6 403,006 564,706
854,539 460,281

Interest receivable and similar income 28,650 -
883,189 460,281

Interest payable and similar expenses 7 555,697 416,929
PROFIT BEFORE TAXATION 327,492 43,352

Tax on profit 8 (267,107 ) (310,170 )
PROFIT FOR THE FINANCIAL YEAR 594,599 353,522

OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

594,599

353,522

Ashberry Healthcare Ltd (Registered number: 04886239)

Balance Sheet
31 December 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 9 14,982,840 12,649,244

CURRENT ASSETS
Debtors 10 1,002,074 687,247
Cash at bank and in hand 377,415 2,417,467
1,379,489 3,104,714
CREDITORS
Amounts falling due within one year 11 3,469,143 2,839,176
NET CURRENT (LIABILITIES)/ASSETS (2,089,654 ) 265,538
TOTAL ASSETS LESS CURRENT
LIABILITIES

12,893,186

12,914,782

CREDITORS
Amounts falling due after more than one
year

12

(5,645,287

)

(5,994,375

)

PROVISIONS FOR LIABILITIES 15 (885,343 ) (1,152,450 )
NET ASSETS 6,362,556 5,767,957

CAPITAL AND RESERVES
Called up share capital 16 10,000 10,000
Fair value reserve 17 2,956,674 2,867,312
Retained earnings 17 3,395,882 2,890,645
SHAREHOLDERS' FUNDS 6,362,556 5,767,957

The financial statements were approved by the Board of Directors and authorised for issue on 30 September 2025 and were signed on its behalf by:





N J Denny - Director


Ashberry Healthcare Ltd (Registered number: 04886239)

Statement of Changes in Equity
for the Year Ended 31 December 2024

Called up Fair
share Retained value Total
capital earnings reserve equity
£    £    £    £   
Balance at 1 January 2023 10,000 2,781,489 2,622,946 5,414,435

Changes in equity
Total comprehensive income - 109,156 244,366 353,522
Balance at 31 December 2023 10,000 2,890,645 2,867,312 5,767,957

Changes in equity
Total comprehensive income - 505,237 89,362 594,599
Balance at 31 December 2024 10,000 3,395,882 2,956,674 6,362,556

Ashberry Healthcare Ltd (Registered number: 04886239)

Cash Flow Statement
for the Year Ended 31 December 2024

2024 2023
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 1,574,545 666,020
Interest paid (555,697 ) (416,929 )
Tax paid - (102,255 )
Net cash from operating activities 1,018,848 146,836

Cash flows from investing activities
Purchase of tangible fixed assets (2,786,334 ) (1,033,687 )
Government grants received - 26,782
Interest received 28,650 -
Net cash from investing activities (2,757,684 ) (1,006,905 )

Cash flows from financing activities
Loan movements in year (178,600 ) 2,556,638
New HP contracts in year (122,616 ) 443,853
Amount withdrawn by directors - (32,041 )
Net cash from financing activities (301,216 ) 2,968,450

(Decrease)/increase in cash and cash equivalents (2,040,052 ) 2,108,381
Cash and cash equivalents at
beginning of year

2

2,417,467

309,086

Cash and cash equivalents at end of
year

2

377,415

2,417,467

Ashberry Healthcare Ltd (Registered number: 04886239)

Notes to the Cash Flow Statement
for the Year Ended 31 December 2024

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

2024 2023
£    £   
Profit before taxation 327,492 43,352
Depreciation charges 452,738 356,681
Government grants - (26,782 )
Finance costs 555,697 416,929
Finance income (28,650 ) -
1,307,277 790,180
Increase in trade and other debtors (314,827 ) (158,760 )
Increase in trade and other creditors 582,095 34,600
Cash generated from operations 1,574,545 666,020

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 December 2024
31.12.24 1.1.24
£    £   
Cash and cash equivalents 377,415 2,417,467
Year ended 31 December 2023
31.12.23 1.1.23
£    £   
Cash and cash equivalents 2,417,467 309,086


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.1.24 Cash flow At 31.12.24
£    £    £   
Net cash
Cash at bank and in hand 2,417,467 (2,040,052 ) 377,415
2,417,467 (2,040,052 ) 377,415
Debt
Finance leases (594,788 ) 122,616 (472,172 )
Debts falling due within 1 year (208,545 ) (40,880 ) (249,425 )
Debts falling due after 1 year (5,555,591 ) 219,480 (5,336,111 )
(6,358,924 ) 301,216 (6,057,708 )
Total (3,941,457 ) (1,738,836 ) (5,680,293 )

Ashberry Healthcare Ltd (Registered number: 04886239)

Notes to the Financial Statements
for the Year Ended 31 December 2024

1. STATUTORY INFORMATION

Ashberry Healthcare Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared in accordance with applicable accounting standards including Financial Reporting Standard 102 The Financial Reporting Standard Applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. The financial statements have been prepared on a going concern basis under the historical cost convention, modified to include certain items at fair value.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

Significant judgements and estimates
Valuation of Properties
The freehold properties owned by the company have been included in the accounts at their Market Value as at 31 December 2024. The valuation has been undertaken by the board of Directors.

Turnover
Turnover is measured at the fair value of the consideration received or receivable net of VAT and trade discounts. The policies adopted for the recognition of turnover are as follows:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
- the amount of revenue can be measured reliably;
- it is probable that the Company will receive the consideration due under the contract;
- the stage of completion of the contract at the end of the reporting period can be measured reliably; and
- the costs incurred and the costs to complete the contract can be measured reliably

Tangible fixed assets
Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life as follows:

Freehold building - 2% and 10% straight line
Plant and machinery - 20% straight line
Motor vehicles - 25% straight line
Furniture, fittings and equipment - 20% straight line

Ashberry Healthcare Ltd (Registered number: 04886239)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued

Financial instruments
The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, and loans to related parties.

Debt instruments (other than those wholly repayable or receivable within one year). including loads and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method unless the effect of discounting would be immaterial, in which case these are stated at cost.

Debt instruments that are payable and receivable within one year, typically trade debtors and creditors, are measured at the undiscounted amounts of cash or other consideration expected to be paid or received.

Taxation
Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax represents the future tax consequences of transactions and events recognised in the financial statements of current and previous periods. It is recognised in respect of all timing differences, with certain exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expense in tax assessments in periods different from those in which they are recognised in the financial statements. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date that are expected to apply to the reversal of timing differences. Deferred tax on revalued non-depreciable tangible fixed assets and investment properties is measured using the rates and allowances that apply to the sale of the asset.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Assets acquired under finance leases are capitalised and depreciated over the shorter of the lease term and the expected useful life of the asset. Minimum lease payments are apportioned between the finance charge and the reduction of the outstanding lease liability using the effective interest method. The related obligations, net of future finance charges, are included in creditors.

Pension costs and other post-retirement benefits
The company operates a defined contribution plan for the benefit of its employees. The contributions are recognised as an expense in the profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds. Once the contributions have been paid the Company has no further payment obligations.

Ashberry Healthcare Ltd (Registered number: 04886239)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by class of business is given below:

2024 2023
£    £   
Rendering of care services 14,451,095 12,525,049
14,451,095 12,525,049

4. EMPLOYEES AND DIRECTORS
2024 2023
£    £   
Wages and salaries 7,936,370 6,321,879
Social security costs 671,375 495,094
Other pension costs 256,330 207,658
8,864,075 7,024,631

The average number of employees during the year was as follows:
2024 2023

Administration and support 15 14
Care home staff 318 263
333 277

2024 2023
£    £   
Directors' remuneration 52,500 85,417
Directors' pension contributions to money purchase schemes 53,645 54,633

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 3 3

5. OPERATING PROFIT

The operating profit is stated after charging:

2024 2023
£    £   
Hire of plant and machinery 53,738 33,658
Other operating leases 32,964 36,728
Depreciation - owned assets 452,738 356,681
Auditors remuneration 14,638 13,000

6. EXCEPTIONAL ITEMS
2024 2023
£    £   
Exceptional items (403,006 ) (564,706 )

Ashberry Healthcare Ltd (Registered number: 04886239)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

During the year the exceptional items relate to transactions in connection with the Company's restructuring that is being undertaken, including the refinancing of the loans.

7. INTEREST PAYABLE AND SIMILAR EXPENSES
2024 2023
£    £   
Bank interest 457,246 369,157
Loan 35,000 28,000
Other interest payable 63,451 19,772
555,697 416,929

8. TAXATION

Analysis of the tax credit
The tax credit on the profit for the year was as follows:
2024 2023
£    £   
Current tax:
UK corporation tax - (17,575 )

Deferred tax (267,107 ) (292,595 )
Tax on profit (267,107 ) (310,170 )

UK corporation tax has been charged at 25% .

Reconciliation of total tax credit included in profit and loss
The tax assessed for the year is lower than the standard rate of corporation tax in the UK. The difference is explained below:

2024 2023
£    £   
Profit before tax 327,492 43,352
Profit multiplied by the standard rate of corporation tax in the UK of
25% (2023 - 25%)

81,873

10,838

Effects of:
Capital allowances in excess of depreciation (135,644 ) (6,937 )

Deferred tax (267,107 ) (292,595 )
Pension provision adjustment 12,055 (3,901 )
Adjust losses carried forward 41,716 (17,575 )
Total tax credit (267,107 ) (310,170 )

Ashberry Healthcare Ltd (Registered number: 04886239)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

9. TANGIBLE FIXED ASSETS
Fixtures
Freehold Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
COST OR VALUATION
At 1 January 2024 12,061,252 1,015,707 1,214,025 509,781 14,800,765
Additions 2,638,735 61,214 69,650 16,735 2,786,334
Disposals - (103,938 ) (156,458 ) - (260,396 )
At 31 December 2024 14,699,987 972,983 1,127,217 526,516 17,326,703
DEPRECIATION
At 1 January 2024 160,070 958,470 913,665 119,316 2,151,521
Charge for year 223,312 19,488 92,633 117,305 452,738
Eliminated on disposal - (103,938 ) (156,458 ) - (260,396 )
At 31 December 2024 383,382 874,020 849,840 236,621 2,343,863
NET BOOK VALUE
At 31 December 2024 14,316,605 98,963 277,377 289,895 14,982,840
At 31 December 2023 11,901,182 57,237 300,360 390,465 12,649,244

Cost or valuation at 31 December 2024 is represented by:

Fixtures
Freehold Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
Valuation in 2022 4,019,113 - - - 4,019,113
Cost 10,680,874 972,983 1,127,217 526,516 13,307,590
14,699,987 972,983 1,127,217 526,516 17,326,703

If freehold property had not been revalued they would have been included at the following historical cost:

2024 2023
£    £   
Cost 9,258,788 7,605,887

Freehold land and buildings were valued on an open market basis on 31 December 2024 by the directors .

10. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 379,469 109,968
Amounts owed by group undertakings - 990
Other debtors 576 2,740
VAT 238,792 174,773
Prepayments and accrued income 383,237 398,776
1,002,074 687,247

Ashberry Healthcare Ltd (Registered number: 04886239)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts (see note 13) 249,425 208,545
Hire purchase contracts (see note 14) 162,996 156,004
Trade creditors 644,094 719,074
Amounts owed to group undertakings 664,989 658,042
Social security and other taxes 184,760 150,574
Other creditors 1,089,034 594,532
Accruals and deferred income 473,845 352,405
3,469,143 2,839,176

12. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans (see note 13) 5,336,111 5,555,591
Hire purchase contracts (see note 14) 309,176 438,784
5,645,287 5,994,375

13. LOANS

An analysis of the maturity of loans is given below:

2024 2023
£    £   
Amounts falling due within one year or on demand:
Bank loans 249,425 208,545

Amounts falling due between one and two years:
Bank loans - 1-2 years 256,550 227,518

Amounts falling due between two and five years:
Bank loans - 2-5 years 5,079,561 5,328,073

The bank loans are secured by way of a fixed and floating charge over the property and assets of the company. The bank loans are charged at 7.89%.

14. LEASING AGREEMENTS

Minimum lease payments under hire purchase fall due as follows:

2024 2023
£    £   
Net obligations repayable:
Within one year 162,996 156,004
Between one and five years 309,176 438,784
472,172 594,788

Ashberry Healthcare Ltd (Registered number: 04886239)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

15. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 885,343 1,152,450

Deferred
tax
£   
Balance at 1 January 2024 1,152,450
Credit to Statement of Comprehensive Income during year (267,107 )
Balance at 31 December 2024 885,343

The deferred tax liabilities relate to amounts payable in future periods based on the carrying amounts of assets in the financial statements and the corresponding indexed cost used in the computation of taxable profits.

16. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
10,000 Ordinary £1 10,000 10,000

17. RESERVES
Fair
Retained value
earnings reserve Totals
£    £    £   

At 1 January 2024 2,890,645 2,867,312 5,757,957
Profit for the year 594,599 594,599
Transfer (89,362 ) 89,362 -
At 31 December 2024 3,395,882 2,956,674 6,352,556

Called-up share capital - represent the nominal value of shares that have been issued

Profit and loss account - represents the distributable reserves of the company and includes all current and prior retained profits and losses,

Fair value reserve - represents the non distributable reserves of the company as a result of the cumulative effect of revaluations of tangible fixed assets

Transfers between the reserves represent movements on the fair value reserve as a result of changes in the deferred tax provision and depreciation charges linked with the revaluation of freehold properties.

18. PENSION COMMITMENTS

The Company operates a defined contributions pensions scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension costs charge represents contributions payable by the Company to the fund and amounted to £256,330 (2023 - £207,658). Contributions totalling £151,225 (2023 - £103,005) were payable to the fund at the balance sheet date and are included in creditors.

Ashberry Healthcare Ltd (Registered number: 04886239)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

19. ULTIMATE PARENT COMPANY

Ashberry Holdings Limited is regarded by the directors as being the company's ultimate parent company.

The company's results have been included in the consolidated financial statements of Ashberry Holdings Limited, copies of which are available on Companies House.

20. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. The parent company Ashberry Holdings Limited prepares publicly available consolidated financial statements.

21. POST BALANCE SHEET EVENTS

Since the year end the company has acquired The Weir Nursing Home Limited.

22. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is N J Denny.